SureTrader Nadex Advertisement
Home > Boards > US Listed > Biotechs >

ARATANA THERAPEUTICS, INC. (PETX)

PETX RSS Feed
Add PETX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 2/17/2017 2:05:33 PM - Followers: 41 - Board type: Free - Posts Today: 0
















Welcome to Aratana Therapeutics 

Aratana Therapeutics is a biopharmaceutical company positioned to deliver innovative prescription medicines that address significant medical needs for cats and dogs (companion animals). 

The company licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies.  Aratana’s team of veterinary drug development experts then advance these compounds through clinical studies designed expressly for demonstrating safety and efficacy in the target specie(s).  Aratana believes the development and commercialization of these therapeutics  will permit veterinarians and companion animal owners to manage pets' medical needs safely and effectively. 

Pets are our passion because pets are family.







About Aratana Therapeutics 


Company Overview 

Companion animals are living longer and therefore are at higher risk of developing an increasing number of medical conditions such as allergies, arthritis, diabetes, cancer and obesity; however, few treatment options exist for these conditions today.   

Aratana is positioned to address this need for better pet care by bringing human science to animal health and providing veterinarians with innovative new medicines that have been designed specifically for treating pets.   

Aratana’s unique “pet-centric” approach differs fundamentally from the current standard, which often involves adjusting the dose of marketed human drugs, which are only presumed to be safe and effective in animals based on human data and veterinary experience. There is significant demand amongst veterinarians and pet owners for higher quality medicines that have been specifically studied and approved by regulatory authorities for each species. Aratana’s team of drug development and commercial experts are dedicated to developing innovative treatments in accordance with regulatory standards to meet these needs. 

Mission and Strategy 

Aratana's mission is to find, develop and commercialize safe and effective therapeutics to enhance the quality of life and strengthen the bond between people and their pets. Our strategy is to become the leading provider of therapeutics developed and approved specifically for the treatment of unmet medical needs in pets. We intend to help shape and define the pet therapeutics market by identifying, acquiring and developing high-value commercial products for companion animals in a cost effective and efficient manner. 

Programs 

Aratana is currently developing several compounds for the large and growing pet health market, including a non-COXIB analgesic for treating pain, an appetite-stimulating molecule for inappetence, and a recently licensed non-opioid local anesthetic for treating post-operative pain. These compounds, which are being developed individually for both cats and dogs, are supported by substantial safety and efficacy data and, if approved by regulatory authorities, could become best- or first-in-class products in the animal health industry. 


The company is actively identifying additional programs to in-license from human health companies in order to expand its development pipeline of animal medicines





Corporate Headquarters
1901 Olathe Blvd 
Kansas City, Kansas 66103
(913) 951-2132

Other Locations
200 Clarendon Street; 54th Floor 
Boston, Massachusetts 02116
(617) 425-9226

 

Business Development Contacts
Julia A. Stephanus 
Chief Commercial Officer
(913) 951-2139
[email protected]

Erick J. Lucera, CPA, CFA 
Vice President, Corporate Development
(913) 951-2136
[email protected]

 

Investor and Media Contacts
Tiberend Strategic Advisors, Inc. 
35 West 35th Street; 11th Floor
New York, New York 10001
(212) 827-0020

Investors - Joshua Drumm, PhD 
(212) 375-2665
[email protected]

Media - Andrew Mielach 
(212) 375-2694
[email protected]

 

Transfer Agent and Registrar
American Stock Transfer & Trust Company, LLC. 
(800) 937-5449










  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PETX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PETX News: Aratana Therapeutics to Report Fourth Quarter and Full Year 2016 Financial Results 02/22/2017 04:05:00 PM
PETX News: Amended Statement of Ownership (sc 13g/a) 02/13/2017 04:57:18 PM
PETX News: Amended Statement of Ownership (sc 13g/a) 02/09/2017 12:25:46 PM
PETX News: Schedule 13g 02/09/2017 10:58:49 AM
PETX News: Amended Statement of Ownership (sc 13g/a) 02/06/2017 12:42:52 PM
PostSubject
#247   Trying to get filled at 6.25 I might chile2 02/17/17 02:05:32 PM
#246   I see you on a couple of tste9 02/15/17 06:52:47 PM
#245   Strong finish yesterday. Looking for continued bullish trend, Mr_Popeye 02/15/17 08:39:03 AM
#244   I'm lucky I sit at desk all day. tste9 02/13/17 12:56:53 PM
#243   There's your dip, good call Mr_Popeye 02/13/17 12:51:17 PM
#242   Getting a good beating today. I have some tste9 02/13/17 12:38:50 PM
#241   Thanks for reply. I have a little bit tste9 02/12/17 10:33:30 AM
#240   Well considering where PETX was before it fell Mr_Popeye 02/11/17 09:06:44 PM
#239   Thanks for post. I was waiting for a tste9 02/11/17 08:57:04 PM
#238   From American Bulls. PETX NASDAQ ARATANA THERAPEUTICS Last Signal:BUY Last Clo Mr_Popeye 02/11/17 02:28:12 PM
#237   I think it's simply the value and people Mr_Popeye 02/10/17 06:27:32 PM
#236   Do you have any thought on why the tste9 02/10/17 06:22:37 PM
#235   I think so. The overreaction seems to be Mr_Popeye 02/10/17 01:15:03 PM
#234   Good movement here today. Sustainable for a decent Rhew123 02/10/17 12:45:33 PM
#233   Agreed - added a few times after the Rhew123 02/10/17 10:24:22 AM
#232   6.17 was a great place to add or Mr_Popeye 02/10/17 08:52:20 AM
#231   Great time to add imo.... Mr_Popeye 02/08/17 10:04:00 AM
#230   And I'm sorry you lost 20% on this Rhew123 02/07/17 02:57:37 PM
#229   Well, mainly cause it was down 18% and Rhew123 02/07/17 02:56:11 PM
#228   Another 8% down why buy if its going lower diddobuyer 02/07/17 02:52:18 PM
#227   Another 8% down why buy if its going lower diddobuyer 02/07/17 02:52:00 PM
#226   Agreed - I added Rhew123 02/06/17 02:19:50 PM
#225   Overreaction itsthebox1 02/06/17 02:16:13 PM
#224   yeah right another pos stock I lost 20% diddobuyer 02/06/17 11:27:00 AM
#223   The sell off of PETX today created a biotech_researcher 02/06/17 10:11:52 AM
#222   IDEXX Laboratories (NASDAQ:IDXX) reports 4Q16 Profit Up 21% Bickema 02/02/17 10:02:48 AM
#221   Agree. grizzly2314 02/02/17 09:11:47 AM
#220   Also good chance they will be bought by kris_kade 02/01/17 06:58:40 PM
#219   Thanks going in. It will be a little tste9 02/01/17 01:14:32 PM
#218   No. Plenty of cash plus revenue should be grizzly2314 02/01/17 12:35:05 PM
#217   Does PETX have to raise money, to keep tste9 02/01/17 12:00:08 PM
#216   "Dr Gunn is full of high praise for michelinvests 01/31/17 09:07:43 AM
#215   Me 2 michelinvests 01/30/17 04:38:20 PM
#214   Yes, I added Rhew123 01/30/17 02:38:33 PM
#213   Anyone adding at these levels?? This appears to grizzly2314 01/30/17 01:31:30 PM
#212   $20 to $25 kris_kade 01/16/17 10:21:25 PM
#211   if PETX bought out, any guessing price? kei 01/14/17 08:59:14 PM
#210   PETX is reacting nicely to the news, Bickema 01/09/17 10:03:35 AM
#209   WOOF just purchased by MARS for a substantial premium. north40000 01/09/17 09:25:06 AM
#208   Why Pet Health Is The Focus Of A Bickema 01/07/17 09:06:21 PM
#207   Thanks for sending me these posts. Bickema 01/03/17 04:17:04 PM
#206   Added more shares good day for it. itsabouttime 12/21/16 04:23:51 PM
#205   PETX romanov5 12/19/16 02:48:18 PM
#204   Again thank you. gl. tste9 12/01/16 07:12:48 PM
#203   No negative results. Simply not much of catalysts. kris_kade 12/01/16 10:00:22 AM
#202   again thanks for post. But why the down tste9 11/30/16 10:43:45 AM
#201   Thank you for post update. Not too many tste9 11/24/16 08:46:10 AM
#200   It is under accumulation with uptrend back to kris_kade 11/23/16 06:17:59 PM
#199   Starting to get squeezed between lower bband and Rhew123 11/23/16 12:52:23 PM
#198   Agree 100%. I have been added last two kris_kade 11/01/16 12:44:29 PM
PostSubject